On ECHEMI
Home > Drugs > Hubei KEYI Pharmaceutical Industry Co., Ltd.
Hubei KEYI Pharmaceutical Industry Co., Ltd.
  • Founded in:

    1997-05-23
  • Country:

    China China
  • Address:

    No. 8, Huanglongshan South Road, East Lake New Technology Development Zone, Wuhan
  • Tax NO.:

    91420000726103295U
  • Registered Funds:

    34.750206 million yuan
  • Email:

Related Drugs
Valacyclovir Hydrochloride
Name Description Content CAS NO. Registered Holders
Valacyclovir Hcl

136489-37-7 138
Acyclovir for injection
Acyclovir.
Name Description Content CAS NO. Registered Holders
Acyclovir

Antiviral drug. It has an inhibitory effect on herpes simplex virus, varicella zoster virus, cytomegalovirus, etc. in vitro. After entering the cells infected by herpes virus, this product competes with deoxynucleoside for viral thymidine kinase or cell kinase, and the drug is phosphorylated into activated acyclovir triphosphate, and then inhibits viral replication in two ways: ① Interfering with viral DNA polymerase and inhibiting viral replication; ② Under the action of DNA polymerase, it binds to the growing DNA chain, causing the extension of the DNA chain to be interrupted. This product has a special affinity for viruses, but has low toxicity to mammalian host cells.

More

Antiviral drug. It has an inhibitory effect on herpes simplex virus, varicella zoster virus, cytomegalovirus, etc. in vitro. After entering the cells infected by herpes virus, this product competes with deoxynucleoside for viral thymidine kinase or cell kinase, and the drug is phosphorylated into activated acyclovir triphosphate, and then inhibits viral replication in two ways: ① Interfering with viral DNA polymerase and inhibiting viral replication; ② Under the action of DNA polymerase, it binds to the growing DNA chain, causing the extension of the DNA chain to be interrupted. This product has a special affinity for viruses, but has low toxicity to mammalian host cells.

59277-89-3 50
Diclofenac diethylamide
Levofloxacin.
Name Description Content CAS NO. Registered Holders
Levofloxacin

This product has a broad-spectrum antibacterial effect and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, and Gram-negative bacteria such as Haemophilus influenzae, Legionella pneumophila, and Neisseria gonorrhoeae. It also has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, and Mycoplasma pneumoniae and Chlamydia pneumoniae, but has poor effects on anaerobic bacteria and enterococci. Its mechanism of action is to inhibit the activity of bacterial DNA gyrase, prevent the synthesis and replication of bacterial DNA, and cause bacterial death.

More

This product has a broad-spectrum antibacterial effect and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, and Gram-negative bacteria such as Haemophilus influenzae, Legionella pneumophila, and Neisseria gonorrhoeae. It also has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, and Mycoplasma pneumoniae and Chlamydia pneumoniae, but has poor effects on anaerobic bacteria and enterococci. Its mechanism of action is to inhibit the activity of bacterial DNA gyrase, prevent the synthesis and replication of bacterial DNA, and cause bacterial death.

100986-85-4 33
Diclofenac diethylamine emulsion
The main ingredient of this product is diclofenac diethylamine
Name Description Content CAS NO. Registered Holders
Diclofenac diethylamine

Extract from the above information

More

Extract from the above information

78213-16-8 11
Bismuth Potassium Citrate
Name Description Content CAS NO. Registered Holders
BISMUTH POTASSIUM CITRATE

Extract from the above information

More

Extract from the above information

57644-54-9 18
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.